Common Contracts
4 similar Market Sales Agreement contracts by Atlanticus Holdings Corp, DARA BioSciences, Inc., Outlook Therapeutics, Inc., Sonnet BioTherapeutics Holdings, Inc.
ATLANTICUS HOLDINGS CORPORATION UP TO $50,000,000 OF COMMON STOCK (no par value per share) AT-THE-MARKET SALES AGREEMENTMarket Sales Agreement • January 2nd, 2024 • Atlanticus Holdings Corp • Personal credit institutions • New York
Atlanticus Holdings Corporation, a Georgia corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Parties”), as follows:
At-the-market SALES AGREEMENTMarket Sales Agreement • May 16th, 2023 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Parties”), as follows:
AT-THE-MARKET SALES AGREEMENTMarket Sales Agreement • February 5th, 2021 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Sonnet BioTherapeutics Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC in its capacity as sales agent for the Company (“BTIG” and, together with the Company, the “Parties”), as follows:
DARA BIOSCIENCES, INC. UP TO $2,730,000 OF COMMON STOCK (par value $0.01 per share) AT-THE-MARKET SALES AGREEMENTMarket Sales Agreement • August 19th, 2013 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
DARA BioSciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Parties”), as follows:
